Clinical Pharmacology: Special safety considerations in drug development and pharmacovigilance.
Research output: Contribution to journal › Article › peer-review
Standard Standard
Clinical Pharmacology: Special safety considerations in drug development and pharmacovigilance. / Hughes, D.; Atuah, K.N.; Hughes, D.A. et al.
In: Drug Safety, Vol. 27, No. 8, 01.01.2004, p. 535-554.
In: Drug Safety, Vol. 27, No. 8, 01.01.2004, p. 535-554.
Research output: Contribution to journal › Article › peer-review
HarvardHarvard
Hughes, D, Atuah, KN, Hughes, DA & Pirmohamed, M 2004, 'Clinical Pharmacology: Special safety considerations in drug development and pharmacovigilance.', Drug Safety, vol. 27, no. 8, pp. 535-554.
APA
Hughes, D., Atuah, K. N., Hughes, D. A., & Pirmohamed, M. (2004). Clinical Pharmacology: Special safety considerations in drug development and pharmacovigilance. Drug Safety, 27(8), 535-554.
CBE
Hughes D, Atuah KN, Hughes DA, Pirmohamed M. 2004. Clinical Pharmacology: Special safety considerations in drug development and pharmacovigilance. Drug Safety. 27(8):535-554.
MLA
Hughes, D. et al. "Clinical Pharmacology: Special safety considerations in drug development and pharmacovigilance.". Drug Safety. 2004, 27(8). 535-554.
VancouverVancouver
Hughes D, Atuah KN, Hughes DA, Pirmohamed M. Clinical Pharmacology: Special safety considerations in drug development and pharmacovigilance. Drug Safety. 2004 Jan 1;27(8):535-554.
Author
RIS
TY - JOUR
T1 - Clinical Pharmacology: Special safety considerations in drug development and pharmacovigilance.
AU - Hughes, D.
AU - Atuah, K.N.
AU - Hughes, D.A.
AU - Pirmohamed, M.
PY - 2004/1/1
Y1 - 2004/1/1
KW - PHARMACOLOGY & PHARMACY
KW - PUBLIC
KW - ENVIRONMENTAL & OCCUPATIONAL HEALTH
KW - TOXICOLOGY
M3 - Article
VL - 27
SP - 535
EP - 554
JO - Drug Safety
JF - Drug Safety
SN - 0114-5916
IS - 8
ER -